Select your cookie preferences

We use essential cookies and similar tools that are necessary to provide our site and services. We use performance cookies to collect anonymous statistics, so we can understand how customers use our site and make improvements. Essential cookies cannot be deactivated, but you can choose “Customize” or “Decline” to decline performance cookies.

If you agree, AWS and approved third parties will also use cookies to provide useful site features, remember your preferences, and display relevant content, including relevant advertising. To accept or decline all non-essential cookies, choose “Accept” or “Decline.” To make more detailed choices, choose “Customize.”

Sign in
Your Saved List Become a Channel Partner Sell in AWS Marketplace Amazon Web Services Home Help

Cancer Genome Characterization Initiatives - Burkitt Lymphoma, HIV+ Cervical Cancer

Cancer Genome Characterization Initiatives - Burkitt Lymphoma, HIV+ Cervical Cancer

This product is part of the AWS Open Data Sponsorship Program and contains data sets that are publicly available for anyone to access and use. No subscription is required. Unless specifically stated in the applicable data set documentation, data sets available through the AWS Open Data Sponsorship Program are not provided and maintained by AWS.

Description

The Cancer Genome Characterization Initiatives (CGCI) program supports cutting-edge genomics research of adult and pediatric cancers. CGCI investigators develop and apply advanced sequencing methods that examine genomes, exomes, and transcriptomes within various types of tumors. The program includes Burkitt Lymphoma Genome Sequencing Project (BLGSP) project and HIV+ Tumor Molecular Characterization Project - Cervical Cancer (HTMCP-CC) project. The dataset contains open Clinical Supplement, Biospecimen Supplement, RNA-Seq Gene Expression Quantification, miRNA-Seq Isoform Expression Quantification, and miRNA Expression Quantification data. This dataset also contains controlled WGS/Targeted Sequencing/RNA-Seq/miRNA-Seq Aligned Reads, and RNA-Seq Splice Junction Quantification

License
How to cite

Cancer Genome Characterization Initiatives - Burkitt Lymphoma, HIV+ Cervical Cancer was accessed on DATE from https://registry.opendata.aws/cgci .

Update frequency
Genomic Data Commons (GDC) is source of truth for this dataset; GDC offers monthly data releases, although this dataset may not be updated at every release.
Support information

Contact: dcf-support@datacommons.io

General AWS Data Exchange support

Resources on AWS

Description

Clinical Supplement, Biospecimen Supplement, RNA-Seq Gene Expression Quantification, miRNA-Seq Isoform Expression Quantification, miRNA-Seq miRNA Expression Quantification

Resource type
S3 Bucket
Amazon Resource Name (ARN)
arn:aws:s3:::gdc-cgci-blgsp-phs000235-2-open
AWS Region
us-east-1

AWS CLI Access (No AWS account required)

aws s3 ls --no-sign-request s3://gdc-cgci-blgsp-phs000235-2-open/
Description

Clinical Supplement, Biospecimen Supplement, RNA-Seq Gene Expression Quantification, miRNA-Seq Isoform Expression Quantification, miRNA-Seq miRNA Expression Quantification

Resource type
S3 Bucket
Amazon Resource Name (ARN)
arn:aws:s3:::gdc-cgci-phs000235-2-open
AWS Region
us-east-1

AWS CLI Access (No AWS account required)

aws s3 ls --no-sign-request s3://gdc-cgci-phs000235-2-open/
Description

WGS/Targeted Sequencing/RNA-Seq/miRNA-Seq Aligned Reads, RNA-Seq Splice Junction Quantification

Resource type
S3 Bucket
Amazon Resource Name (ARN)
arn:aws:s3:::gdc-cgci-phs000235-2-controlled
AWS Region
us-east-1

Usage examples

Publications